Form 4: Macrogenics Director Margaret Liu Reports Stock Option and RSU Grants

Director Margaret Liu reports the acquisition of stock options and restricted stock units (RSUs) in Macrogenics Inc.

Summary

• On May 21, 2024, Director Margaret Liu reported the acquisition of 16,500 stock options with an exercise price of $4.26 and 6,500 restricted stock units (RSUs) in Macrogenics Inc.
• The stock options vest in monthly increments starting one month from the grant date and expire on May 21, 2034.
• The RSUs will vest one year after the grant date or the day prior to the next annual meeting, whichever is earlier.
• Following the transaction, Ms. Liu directly owns 16,500 stock options and 6,500 RSUs.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. It doesn't inherently suggest positive or negative sentiment, but rather reflects normal business operations.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedules for the options and RSUs incentivize long-term performance.

Industry Context

Stock options and RSUs are common forms of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• The grant of stock options and RSUs may have a minor dilutive effect on existing shareholders.

Key Dates